Last 47 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Hologic, Inc.'s quarterly P/E stands at 23.6x, up 13.0% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 12.6% YoY to 16.3x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 30.53 | 23.58 | 20.24 | 18.90 | — | 20.86 | 26.80 | 22.64 | 27.07 | 17.34 | 46.89 | — | 23.19 |
| — | +13.0% | -24.5% | -16.5% | — | +20.3% | -42.9% | — | +16.7% | -30.5% | +36.6% | — | +119.5% | |
| P/S Ratio | 4.14 | 4.02 | 3.61 | 3.58 | 3.44 | 4.12 | 4.86 | 4.34 | 4.55 | 4.24 | 4.54 | 5.08 | 4.91 |
| — | -2.6% | -25.7% | -17.5% | -24.3% | -2.7% | +7.2% | -14.5% | -7.3% | -2.4% | +6.1% | +13.4% | +46.2% | |
| P/B Ratio | 3.43 | 3.21 | 3.01 | 3.03 | 3.00 | 3.53 | 3.75 | 3.55 | 3.82 | 3.69 | 3.42 | 3.86 | 3.80 |
| — | -9.1% | -19.8% | -14.7% | -21.6% | -4.3% | +9.6% | -8.1% | +0.5% | +0.7% | +2.3% | +7.4% | -5.5% | |
| P/FCF | 18.44 | 19.55 | 11.68 | 11.09 | 26.79 | 29.60 | 14.27 | 11.80 | 17.51 | 23.58 | 20.79 | 16.87 | 28.93 |
| — | -34.0% | -18.2% | -6.1% | +53.0% | +25.6% | -31.4% | -30.0% | -39.5% | +13.4% | -30.1% | +14.6% | +505.0% | |
| EV / EBITDA | 17.39 | 16.31 | 12.51 | 11.89 | 54.00 | 14.49 | 16.19 | 13.97 | 14.91 | 15.53 | 20.83 | 60.74 | 14.47 |
| — | +12.6% | -22.7% | -14.9% | +262.1% | -6.7% | -22.3% | -77.0% | +3.1% | +13.6% | +22.2% | +392.3% | +101.6% | |
| EV / EBIT | 24.69 | 16.69 | 16.50 | 14.63 | 6227.48 | 15.84 | 19.45 | 16.21 | 19.39 | 20.49 | 24.95 | 126.05 | 16.66 |
| — | +5.4% | -15.2% | -9.8% | +32017.5% | -22.7% | -22.0% | -87.1% | +16.4% | +14.9% | -1.0% | +642.0% | +97.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Hologic, Inc.'s operating margin was 22.6% in Q1 2026, up 0.0 pp QoQ and up 0.1 pp YoY. The trailing four-quarter average of 17.3% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.0% | 56.0% | 60.9% | 56.3% | 37.5% | 56.8% | 56.4% | 55.4% | 55.3% | 56.0% | 52.9% | 37.3% | 57.1% |
| — | -1.5% | +7.9% | +1.7% | -32.1% | +1.4% | +6.7% | +48.4% | -3.2% | -2.6% | -2.0% | -31.9% | -13.4% | |
| Operating Margin | 17.4% | 22.6% | 22.6% | 24.9% | -0.7% | 22.5% | 23.3% | 24.1% | 23.9% | 19.6% | 14.0% | 0.1% | 26.5% |
| — | +0.6% | -3.0% | +3.1% | -102.9% | +15.0% | +66.1% | +16865.5% | -9.8% | -19.9% | -5.2% | -99.5% | -35.9% | |
| Net Margin | 13.8% | 17.1% | 17.8% | 19.0% | -1.7% | 19.7% | 18.1% | 19.2% | 16.7% | 24.3% | 9.6% | -4.1% | 21.3% |
| — | -13.1% | -1.3% | -1.0% | -110.4% | -19.2% | +88.6% | +567.4% | -21.6% | +39.5% | -23.0% | -118.1% | -32.9% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.1% | 3.5% | 3.8% | 4.1% | -0.4% | 4.1% | 3.5% | 4.0% | 3.6% | 5.1% | 1.8% | -0.8% | 4.2% |
| — | -14.3% | +6.9% | +3.7% | -110.4% | -20.4% | +99.4% | +614.0% | -14.9% | +35.6% | -26.1% | -116.6% | -57.0% | |
| ROA | 6.2% | 2.0% | 2.1% | 2.2% | -0.2% | 2.2% | 2.0% | 2.2% | 2.0% | 2.8% | 1.0% | -0.4% | 2.3% |
| — | -12.4% | +6.2% | +1.7% | -110.2% | -19.7% | +101.8% | +612.5% | -15.2% | +37.2% | -23.9% | -117.8% | -51.9% | |
| ROIC | 9.4% | 3.1% | 3.1% | 3.4% | -0.1% | 3.1% | 3.2% | 3.6% | 3.5% | 2.8% | 1.9% | 0.0% | 3.7% |
| — | +1.7% | -2.8% | -5.3% | -102.7% | +9.1% | +69.6% | +18209.8% | -6.1% | -21.2% | -1.7% | -99.5% | -51.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Hologic, Inc.'s Debt/EBITDA ratio is 9.6x, up from 8.3x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 15.9% YoY to 4.04x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.52 | 0.48 | 0.52 | 0.52 | 0.55 | 0.53 | 0.52 | 0.52 | 0.53 | 0.55 | 0.58 | 0.55 | 0.54 |
| — | -9.7% | +0.4% | +0.8% | +3.4% | -3.9% | -10.5% | -5.7% | -1.2% | -0.9% | -3.4% | -3.7% | -16.9% | |
| Debt / EBITDA | 2.59 | 9.57 | 8.30 | 7.77 | 36.58 | 8.36 | 8.73 | 8.09 | 8.10 | 9.00 | 13.96 | 34.38 | 8.06 |
| — | +14.5% | -4.9% | -4.0% | +351.4% | -7.0% | -37.5% | -76.5% | +0.5% | +10.0% | +18.3% | +351.3% | +82.4% | |
| Current Ratio | 3.75 | 4.04 | 3.75 | 3.55 | 3.24 | 3.49 | 3.69 | 3.99 | 3.97 | 3.89 | 3.47 | 4.42 | 4.41 |
| — | +15.9% | +1.8% | -10.9% | -18.3% | -10.3% | +6.4% | -9.8% | -10.0% | -7.6% | -15.8% | +13.2% | +48.3% | |
| Quick Ratio | 3.06 | 3.32 | 3.06 | 2.81 | 2.52 | 2.78 | 3.03 | 3.32 | 3.29 | 3.18 | 2.95 | 3.73 | 3.69 |
| — | +19.3% | +0.9% | -15.4% | -23.4% | -12.6% | +2.6% | -10.9% | -10.9% | -9.0% | -14.4% | +12.2% | +43.5% | |
| Interest Coverage | 16.95 | 9.32 | 25.00 | 9.13 | 0.02 | 9.11 | 7.95 | 8.55 | 7.55 | 8.36 | 6.18 | 1.44 | 11.27 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Deep dive into HOLX consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HOLX stock.
Hologic, Inc.'s current P/E is 30.5x. The average P/E over the last 3 quarters is 20.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Hologic, Inc.'s current operating margin is 17.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Hologic, Inc.'s business trajectory between earnings reports.